Market Leadership in Sight as Eli Lilly’s Oral ...

By Rene Pretorius

April 21, 2025

Summary Eli Lilly's oral GLP-1 medication, orforglipron, has completed a Phas...
A Shared-Value Model for Enhancing Diabetes Care in South Africa
Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefit...
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
Cost Savings and Impact of Comprehensive Medication Management in Healthcare
AI Kidney Disease Detection: Transforming Eye Screenings for Diabetic Patients
Semaglutide NAION Risk: EMA Review Initiated Amid Conflicting Evidence
AI Tool Predicts Type 2 Diabetes Risk via ECG Up to 10 Years Early
Zepbound Outperforms Wegovy in Weight Loss Trial
Dark Chocolate: A Sweet Ally Against Type 2 Diabetes and More
Addressing Physical Inactivity in MENA and Beyond
Global Diabetes Trends and Treatment Gaps: 1990-2022 Analysis
Urgent Call for Universal Diabetes Care in Europe Amidst Political Apathy